Source: Iryna Imago / Shutterstock.com
With its epic run over the past month, ATNF stock has rallied far above penny-stock status (less than $5 per share). But, with pulling back to single-digit prices, you may want to keep it on your radar.
What’s been behind the dramatically increased interest in 180 Life Sciences? Increased awareness of the potential of its therapeutic candidates by Reddit investors helped to fuel its initial surge starting in March. But, recent news of insider buying helped this former penny stock rally above $10 per share.
So, why could shares pull back? And, why may it be a great opportunity at lower prices? Namely, its possibility in bringing fibrosis and anti-TNF (anti-tumor necrosis factor) therapies to market. However, recent developments have been minimal. In turn, it’s hard to tell whether shares can continue to climb. Or, if there’s risk of a selloff just around the corner.
Give private jabs a shot bangkokpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bangkokpost.com Daily Mail and Mail on Sunday newspapers.
SHARE
India’s ambitious coronavirus vaccination drive is falling victim to a growing mistrust with almost half of beneficiaries skipping their shots over fears of side effects, technical glitches and expectations of an ebbing pandemic.
Prime Minister Narendra Modi launched the world’s biggest vaccination drive on January 16 to inoculate 300 million vulnerable people from the 1.4 billion population in the nation hit second-hardest worldwide by the pandemic, with 10.6 million confirmed cases and 153,000 deaths from Covid-19.
But 10 days into the drive, many vaccination centres nationwide are witnessing a shortfall in anticipated turnout from priority groups, at times receiving only half of the expected numbers, as doctors, nurses and other key frontline workers avoid taking the shots.
endIndex:
Metro Manila (CNN Philippines, January 27) Can people with allergies receive the COVID-19 vaccine made by biopharmaceutical giant Pfizer?
DOH Undersecretary Maria Rosario Vergeire on Wednesday said individuals who have food and drug allergies can still get the Pfizer vaccine provided they have a certification from their doctors saying they can receive the shot.
But the vaccine is not recommended for people who have suffered severe allergic reactions to other types of vaccines and to any ingredient of Pfizer s vaccine. This was after some people experienced life-threatening allergies after being inoculated with the Pfizer jab. However, these serious allergic reactions are said to be rare. Side effects are usually mild similar to common vaccine reactions.